Concepedia

Publication | Open Access

Abatacept (CTLA-4Ig) treatment reduces T cell apoptosis and regulatory T cell suppression in patients with rheumatoid arthritis

DOIFull Paper Access

59

Citations

32

References

2015

Year

Michael Bonelli, Lisa Göschl, Stephan Blüml, Thomas Karonitsch, Kiyoshi Hirahara, Elisabeth Ferner, Carl-Walter Steiner, G Steiner, Josef S Smolen, Clemens Scheinecker
Lara D. Veeken

Abstract

CTLA-4Ig therapy in RA patients exerts effects beyond the suppression of T cell activation, which has to be taken into account as an additional mechanism of CTLA-4Ig treatment.

References

YearCitations

Page 1